Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics (ASRT) Financial Statements


Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.953; its P/E ratio is -0.26; Assertio Therapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 32.98M$ 35.63M$ 40.99M$ 42.47M$ 50.35M
Gross Profit$ 23.26M$ 28.57M$ 36.22M$ 42.47M$ 50.35M
EBIT$ -31.25M$ -228.13M$ 13.08M$ -4.47M$ 9.89M
EBITDA$ -26.35M$ -217.67M$ 19.66M$ 2.16M$ 9.52M
Net Income Common Stockholders$ -57.38M$ -279.54M$ 8.47M$ -3.48M$ 88.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 73.44M$ 76.89M$ 70.17M$ 68.60M$ 64.94M
Total Assets$ 286.42M$ 380.03M$ 405.18M$ 414.27M$ 413.91M
Total Debt$ 38.51M$ 38.87M$ 38.25M$ 38.62M$ 66.87M
Net Debt$ -34.93M$ -38.02M$ -31.92M$ -29.98M$ 1.93M
Total Liabilities$ 148.42M$ 187.16M$ 150.91M$ 163.61M$ 188.19M
Stockholders Equity$ 138.00M$ 192.87M$ 254.27M$ 250.66M$ 225.72M
Cash Flow-
Free Cash Flow$ 5.61M$ 2.58M$ 17.90M$ 22.61M$ 26.42M
Operating Cash Flow$ 5.71M$ 2.58M$ 18.60M$ 22.72M$ 26.70M
Investing Cash Flow$ -239.00K$ 4.14M$ -703.00K$ -105.00K$ -25.78M
Financing Cash Flow$ -8.91M$ -10.00K$ -16.33M$ -18.95M$ -798.00K
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis